期刊文献+

中国汉族人群不同性别细胞色素氧化酶CYP2C19基因多态性的比较 被引量:10

Comparison of genetic polymorphism of cytochrome CYP2C19 between men and women in Chinese population
在线阅读 下载PDF
导出
摘要 目的 考察性别对中国汉族人群细胞色素氧化酶CYP2C19遗传多态性的影响。方法 应用限制性片段长度多态性分析法 (PCR RFLP)对 14 0名男性和女性中国健康志愿者进行了基因多态性分析。结果 男性中基因型为野生型纯合子wt mt占 4 4 2 3% (2 3 5 2 ) ,基因型为杂合子wt m1和wt m2占 4 4 2 3% (2 3 5 2 ) ,基因型为突变型纯合子m1 m1和m1 m2占 11 5 4 % (6 5 2 ) ;而女性中基因型为野生型纯合子wt wt占 35 2 3% (31 88) ,基因型为杂合子wt m1和wt m2占 5 0 0 % (44 88) ,基因型为突变型纯合子m1 m1和m1 m2占 14 82 % (13 88)。在本实验中未发现m2 m2基因型。结论 在中国男性和女性受试者中 ,wt wt和m1 m1的发生率无显著差别。性别对中国汉族人群细胞色素氧化酶CYP2C19遗传多态性的影响在统计学上无差别。 Aim To assess the effect of gender on genetic polymorphism of cytochrome CYP2C19 in Chinese population. Methods The genetic polymorphism of 140 healthy Chinese were analysed by PCR-RFLP (restriction fragment length polymorphism). Results Of 52 genotyped male subjects, 23 (44.23%) were homozygous for wildtype (wt/wt), 6 (11.54%) were homozygous for CYP2C19 m1 (m1/m1), and 23 (44.23%) were heterozygous for CYP2C19 m1 or CYP2C19 m2 (wt/m1 or wt/m2); and among the 88 genotyped female subjects, 31 (35.23%) were homozygous for wildtype (wt/wt), 13 (14.82%) were homozygous for CYP2C19 m1 (m1/m1), and 44 (50.0%) were heterozygous for CYP2C19 m1 or CYP2C19 m2 (wt/m1 or wt/m2); no homozygous genotype for CYP2C19 m2 (m2/m2) was found in the study. Conclusion There is no statistical difference in ocurance of wt/wt and m1/m1 between in male and in female, so gender have no significant effect on genetic polymorphism of cytochrome CYP2C19.
出处 《药学学报》 CAS CSCD 北大核心 2004年第3期161-163,共3页 Acta Pharmaceutica Sinica
关键词 中国 汉族人群 性别 细胞色素 氧化酶 CYP2C19基因 多态性 cytochrome CYP2C19 genotype genetic polymorphism
  • 相关文献

参考文献6

  • 1[1]Xiao ZS, Goldstein JA, Xie HG, et al. Differences in the incidence of the polymorphism affecting the S-mephenytoin phenotype in Chinese Han and Bai populations and identification of a new rare CYP2C19 mutant allele [J]. J Pharmcol Exp Ther, 1997,281(1):604-609.
  • 2[2]Xie HG, Huang SL, Xu ZH, et al. Evidence for the effect of gender on activity of S-mephenytoin 4′-hydroxylase (CYP2C19) in a Chinese population [J]. Pharmacogenetics, 1997,7(2):115-119.
  • 3[3]Kupfer A, Preisig R. Pharmacogenetics of mephenytoin: a new drug hydroxylation polymorphism in man [J]. Eur J Clin Pharmacol, 1984,26:753-759.
  • 4[4]Hadidi HH, Irshaid YM, Woosley RL, et al. (S)-Mephenytoin hydroxylation phenotypes in a Jordanian population [J]. Clin Pharmacol Ther, 1995,58:542-547.
  • 5[5]Evans DAP, Krahn P, Narayanan N. The mephenytoin (cytochrome P4502C19) and dextromethorphan (cytochrome P4502D6) polymorphisms in Saudi Arabians and Filipinos [J]. Pharmacogenetics, 1995,5:64-71.
  • 6[6]Ededi Ti, Hajiloo L, Butler M, et al. (S)-Mephentoin 4′-hydroxylation in African-Americans (Abstract) [J]. J Clin Pharmacol, 1994,34:1032-1036.

同被引文献84

引证文献10

二级引证文献164

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部